Dysbiosis in the gut microbiome due to antibiotic usage can persist for extended periods of time, impacting host health and increasing the risk for pathogen colonization. The specific factors associated with variability in gut microbiome recovery remain unknown.
Introduction
The human gut microbiome harbors trillions of bacteria providing diverse metabolic capabilities and with essential roles in host health, particularly energy metabolism, immune homeostasis, and xenobiotic metabolism 1 . A stable consortium of commensal microbiota is also believed to play a key role in resisting colonization by pathogens, with dysbiosis being associated with increased risk for infections 2, 3 . Several recent studies have further highlighted the importance of the gut microbiome for host health, particularly in infants and the elderly, with loss of diversity and dysbiosis being associated with various metabolic, immunological and neurological diseases 4 , and poorer response to cancer immunotherapy 5, 6 .
Among the factors that can perturb the gut microbiome, antibiotic usage is known to be a major one that can cause profound and long-term alterations [7] [8] [9] . As antibiotics are widely used in healthcare, their impact on host health through microbiome dysbiosis is likely to be significant and has not been fully quantified till date 10, 11 . In terms of acute response, antibiotic associated diarrhea is a common complication, while in the medium term recovery of the microbial community can be slow and variable [7] [8] [9] and conditional on the initial state 12 . Antibiotic use can also select for drug resistance genes and organisms, thus creating a reservoir for onward transmission of resistance cassettes 13, 14 . Epidemiological and model organism studies suggest that long-term consequences of antibiotic usage include immunological diseases in children 15 , metabolic diseases in adults 16 , and increased risk for infections (e.g. by Clostridium difficile 17 ) in the elderly 18 .
Despite the mounting evidence on the importance of gut microbiome function and how antibiotic usage can severely impact it, we still do not know what enables microbiome recovery. In particular, we do not know whether specific groups of microbial taxa and the functions they perform accelerate or impede recovery and explain the variability that is seen across individuals [7] [8] [9] 12 . Ecological interactions are known to play a key role in the recovery of many ecosystems 19, 20 but an analogous understanding is not currently available for the gut microbiome. A systems-level comprehension of the processes underlying gut microbiome recovery could thus aid in the design of rational interventions that reduce side-effects of antibiotic treatment and promote host health.
RESULTS

Identifying a microbial signature associated with gut microbiome recovery post antibiotic treatment
In order to identify microbial markers associated with gut microbiome recovery, we assembled and systematically analyzed data from 4 different cohorts (a total of 117 individuals with >500 samples). These cohorts represent individuals from 4 different countries on 3 continents (Singapore, Canada 12 , England 8 , Sweden 8 ), a wide range of age groups (21-81) and using different classes of antibiotics, allowing us to infer unifying factors promoting recovery ( Table 1) . One of the cohorts is new and has not been previously analyzed (deep shotgun metagenomic sequencing of 74 samples, with >80 million reads on average), involving mostly elderly subjects from Singapore receiving inpatient antibiotic treatment (manuscript in preparation; Suppl. Data File 1).
Overall, the diversity of the assembled cohorts enabled robustness in the analysis (via cross-validation; see Methods) and ensured generality of results. In addition, each cohort was analyzed independently to account for cohort-specific biases, and the results were aggregated through meta-analysis.
Metagenomic data from each cohort was systematically re-processed using appropriate analysis pipelines (16S rRNA or Shotgun metagenomic sequencing; Methods). For uniform analysis and to get balanced groups, subjects were stratified within each cohort based on median taxonomic diversity of the microbial community post antibiotics into 'recoverers' and 'non-recoverers'. Recoverers exhibited a U-shaped recovery profile for gut microbial diversity, while non-recoverers start with a slightly lower median initial diversity and have even further reduced diversity up to 3 months post antibiotics (Fig. 1A) . As expected, post-antibiotic microbiomes for recoverers were found to be more similar to pre-antibiotic microbiomes compared to non-recoverers, whose microbiomes generally appear to be diverged from unperturbed communities and dysbiotic (Mann-Whitney test p-value < 1.4×10 -12 ; Fig. 1B, C) . This pattern was seen to be consistent across cohorts and using different diversity metrics (Suppl. Fig. S1 ). In agreement with the notion that recovery of microbiome diversity is beneficial to the host, we also noted an enrichment of species that are known to protect against pathogen colonization in the post-antibiotic gut microbiomes of recoverers versus non-recoverers (Suppl. Note 1, Suppl. Tab. S1).
To determine microbial taxa with a role in microbiome recovery, a two-stage approach and cross-cohort validation strategy was used to increase sensitivity and specificity of the association analysis (Methods; Suppl. Data File 2; 56 bacterial species in stage 1). Overall, 20 microbial species were identified to be significantly associated with microbiome recovery in at least two cohorts (Recovery Associated Bacteria -RAB; Table 2 ), with 6 species identified in 3 cohorts and 2 in all 4 cohorts (Bacteroides uniformis and Alistipes putredinis; Fig. 1D ). The observed validation across diverse cohorts highlights the robustness of the associations that were observed for various taxa. In general, variability across cohorts is expected given the differences in important biological factors that could influence the gut microbiome such as diet 21 , environment 22 , genetics 23 and the antibiotics used, though some differences could be technical as well (e.g. 16S rRNA vs Shotgun metagenomic sequencing). It is interesting, therefore, that despite this expected variability common associations emerge, particularly in terms of genus level homogeneity of the results (e.g. Bacteroides species; Fig. 1D ; Table 2 ). We noted that many RABs have been previously shown to have beneficial impact on host health and negatively correlated with disease states, e.g.
Bacteroides uniformis
and Parabacteroides merdae have been observed to be negatively associated with Inflammatory bowel disease and obesity 24 , Faecalibacterium prausnitzii and Roseburia inulinivorans are known for their butyrate producing and antiinflammatory properties [24] [25] [26] [27] , and Bacteroides thetaiotamicron and Bifidobacterium species are known for their ability to prevent pathogen colonization [27] [28] [29] (Table 2) .
However, not all RABs are as well characterized for their contribution to gut health and importantly, their role in resilience and recovery of the gut microbiome after antibiotic treatment remains unknown.
We further investigated the abundance patterns of RABs across various treatment stages (pre-, during and post-antibiotics; Methods) and noted that while most were enriched before treatment (in recoverers vs non-recoverers; e.g. Bacteroides uniformis, Bacteroides thetaiotamicron, Alistipes putredinis and Parabacteroides distasonis), some were enriched in later timepoints, indicating that they may play a secondary/synergistic role in recovery as explored further later in the manuscript (Suppl. Fig. S2 ; e.g.
Bifidobacterium adolescentis and Faecalibacterium prausnitzii).
In addition, we explored the use of machine learning models to predict post-antibiotic recovery status from pretreatment taxonomic abundances for an individual and observed that models with moderate levels of accuracy could be obtained (70.4% from leave-one-out cross validation; Suppl. Note 2).
Enrichment in carbohydrate degradation and energy metabolism capabilities is associated with bacterial growth and gut microbiome recovery
To understand microbial functions and the mechanism behind microbiome recovery, we further analyzed the metagenomic datasets that were available as part of this study (CA and SG cohorts; Table 1 ). As resistance to antibiotics could facilitate recovery, as a first hypothesis, we looked at the resistomes of recoverers and non-recoverers to see if they could explain the taxonomic differences observed (Methods). We noted that among the RABs, while resistance genes from Bacteroides and Alistipes species were slightly enriched in the resistomes of recoverers vs non-recoverers (not significant; Suppl. Fig.   3 ), genes from other RABs were not enriched in the resistomes, suggesting that other microbial functions may play a complementary role for facilitating recovery. We then compared gene families and pathways in the metagenomes of recoverers and nonrecoverers to more generally identify functional capacities associated with microbiome recovery (Methods; FDR adjusted p-value < 0.1 and LDA score > 1.25; Suppl. Data File 3), with the analysis being restricted to pre-and during stages of antibiotic treatment to enrich for functions playing a primary role in recovery. This comparison identified a core set of growth-associated pathways pertaining to the biosynthesis of amino acids, nucleotides, co-factors and cell wall constituents (Fig. 2) . In addition, pathways involved in carbohydrate degradation and energy production were also Ecological interactions often play a key role in the recovery of an ecosystem 19, 20 . To further study the inter-relationships between the various RABs, we sought to reconstruct a microbial 'food-web' that captures dependency relationships between bacteria in the gut microbiome. Association rule mining is a commonly used data mining technique to infer dependency relationships and we introduce its use here in the microbiome context. Bacteroides uniformis and other Bacteroides and group C. coccoides species 34 (Suppl.
Data File 6).
We further investigated whether, as with most natural ecosystems, the gut microbial community could be represented by a pyramidal web, where the presence of a large number of species could be influenced by a few primary colonizers. One of the goals in this analysis was to check whether a subset of the RABs acted as primary colonizers facilitating the growth and recovery of the other species constituting the microbiome. We organized the 'food-web' network in terms of taxa that primarily have outgoing edges and thus support the growth of other bacteria (primary colonizers), those that have both outgoing and incoming edges (secondary colonizers), and those that primarily have incoming edges and thus depend on others for their growth (tertiary colonizers; Fig.   4A ). Interestingly, RABs were present as primary and tertiary colonizers but not as secondary colonizers. In addition, the group of RABs that were primary colonizers were all from cluster 1 with mucin degrading capabilities, while cluster 2 RABs were restricted to being tertiary colonizers (plant and animal carbohydrate degrading). These observations are in agreement with our expectation that while some of the RABs may be essential to microbiome recovery and act as keystone species (primary colonizers), others may only play a supportive role or serve as indicator species for microbiome recovery (tertiary colonizers).
Overall, the carbohydrate degradation profiles of RABs and their inter-relationships in the food-web suggest a model for how they interact in the context of microbiome recovery ( Fig. 4B) . RABs that belong to cluster 1 can degrade mucin in addition to dietderived carbohydrates, making them adept as primary host colonizers that can also break down complex carbohydrates for use as energy sources by other bacteria. This can facilitate the growth of non-host-colonizing, complex carbohydrate degraders in the gut, as well as other bacteria that rely on the simple sugars produced for their growth.
Furthermore, production of SCFAs (particularly butyrate) by RABs and the recovering bacterial community can stimulate mucin production by colonocytes providing a positive feedback loop that can contribute to accelerated microbiome recovery 35, 36 .
Primary and tertiary colonizing RABs synergistically enhance microbiome recovery in vivo
Microbiome recovery is likely to be a multi-stage process involving several bacteria with different roles in different individuals. To begin to understand these interactions based on the RABs identified in this study, we conducted a proof-of-concept experiment in a mouse model to see if some of our human observations could also be qualitatively recapitulated in mice. Specifically, we gave mice antibiotics for 5 days, followed by oral adolescentis -Bt+Ba, Bacillus spp. and B. adolescentis -Bsp+Ba; Methods). Stool samples were then collected every three days for up to 22 days and analyzed using shotgun metagenomic sequencing (Methods; Fig. 5A ). In total, the study involved 6 groups, with 2-6 cages per group (each cage with 2 mice) and 9 timepoints (243 metagenomic libraries).
Overall, all treatment groups exhibited a >3-log reduction in microbial biomass after antibiotic treatment as expected (Methods; Fig. 5B ). However, starting from 1 day after gavage (day 7), and more noticeably 4 days after gavage (day 10), the Bt and Bt+Ba groups exhibited similarly enhanced recovery (>100×) of microbial biomass compared to other groups ( Fig. 5B; Suppl. Fig. S6A ). This is not explained by colonization of the gavaged species alone, as reads belonging to them were removed before doing this analysis. Interestingly, despite being a known probiotic, gavage with Ba alone did not promote enhanced recovery of biomass, while Bt+Ba supported more stable recovery compared to Bt alone ( Fig. 5B; Suppl. Fig. S6B ). While the Bt and Bt+Ba groups converge to their microbial biomass at pre-antibiotic levels by day 10, all other groups continue to have lower biomass at day 22. Similar trends were also seen in terms of microbial community profiles, with the Bt and Bt+Ba groups being more similar to the diversity of the pre-antibiotic microbiome at day 10 than in other groups (Suppl. Fig.   S6B ). However, the Bt+Ba group appears to be better in recovering a pre-antibiotic microbiome at day 22 compared to Bt alone, indicating that synergistic interactions between Bt and Ba may play a role here.
The Bt and Bt+Ba groups also exhibited lower levels of Enterobacteriaceae compared to other groups from day 10 onwards (Fig. 5C) , and similar patterns were seen for other potential pathogens as well (e.g. Clostridium difficile, Chlamydia trachomatis and Staphylococcus aureus). These observations are suggestive of a form of colonization resistance that may be provided by the enhanced microbiome recovery in these two groups. Recapitulating the observations in human cohorts, we also observed enhanced relative abundance of enzymes for plant and animal cell wall degradation as well as mucin degradation in the groups exhibiting faster recovery (Fig.   5D, E) . As a control comparison, peptidoglycan degrading enzymes were not specifically enriched in the Bt and Bt+Ba groups, in agreement with our earlier observation that these functions are not defining characteristics for RABs (Fig. 5F , Suppl. Fig. S5 ).
Discussion
The bacterial species and functions identified in this study provide a first, data-driven view of how shared microbial factors contribute to gut microbiome recovery in diverse human cohorts around the world. Our findings emphasize the central role of enabling energy harvest from diet and the ability to colonize the host in the keystone species that underpin ecological recovery, while antibiotic resistance in general plays a less important role. As environmental factors strongly influence the gut microbiome 22 , the specific keystone species that are important for an individual could additionally vary with host and dietary factors. Uncovering these in larger cohorts should be feasible using similar analytical approaches as used here, and could help train antibiotic and environment-specific machine learning models to predict microbiome recovery. Such models would have clinical utility, especially for at-risk elderly or cancer patients, to guide targeted intervention and prevention strategies.
Consistent with our emerging understanding of how diet modulates the gut microbiome 21, 22 , another perspective from which to see our results is the importance of feeding gut bacteria correctly (in addition to having the right species) to promote recovery. Many of the identified RABs are specialist carbohydrate fermenters (e.g. pectin) and a high fiber/low fat diet could aid in selecting and expanding them. For example, in a study on how gut microbiota differ in twins discordant for obesity control RABs is likely more feasible using in vitro co-culture 42 or in silico metabolic models 43, 44 .
Metabolic modeling could, in particular, help explore the contributions of different carbohydrate degradation genes and processes to microbiome recovery 44 , especially for many anaerobic bacteria that are hard to culture or genetically modify 45 . Such investigations could also be informative in understanding the contributions of core and accessory genomes within a species and whether strain-level differences could cause variability in microbiome recovery across individuals.
Conceptually, the microbial 'food-web' as data-mined in this study is a powerful resource for organizing our understanding of how microbes interact and assemble in the human gut. By using a large database of human gut microbiome profiles, we can determine microbial assemblages that are feasible and the dependency relationships that they suggest. These can then help interpret longitudinal studies of recovery and infer the succession of species that play a role. While our current work suggests that introduction of primary colonizers such as B. thetaiotamicron may be a necessary and sufficient way to reduce dysbiosis in comparison to existing probiotics such B.
adolescentis, synergistic combinations could provide other benefits such as colonization resistance against opportunistic pathogens. Further studies of cross-feeding interactions in the 'food-web' may also help identify prebiotics that could serve as supplements to accelerate the process of gut microbiome recovery. In general, understanding microbiome recovery post antibiotic treatment sets the stage for a more general understanding of how microbiome dysbiosis in other diseases could be reverted back to a healthy state using individual-specific pre-and probiotic formulations. Table 1 ). In both cohorts, healthy volunteers were given antibiotics and fecal samples analyzed for day 0 (pre-antibiotic), day 7 (during treatment) and for one and two month follow-ups (post treatment).
METHODS
For the CA, EN and SW cohorts, all antibiotic treated subjects with data from the 3 treatment stages were further analyzed to identify recovery associated bacterial taxa and functions.
DNA extraction and sequencing for SG cohort
Extraction of DNA from stool samples was carried out using PowerSoil DNA Isolation Kit (MoBio Laboratories, California, USA) with minor modifications to the manufacturer's protocol (volume of solutions C2, C3 and C4 were doubled and centrifugation time was extended to twice the original duration). Purified DNA was eluted in 80µl of Solution C6.
DNA libraries were prepared by using 20ng of extracted DNA re-suspended in a volume of 50µl and subjected to shearing using Adaptive Focused Acoustics TM (Covaris, sequencing instrument to generate >80 million 2×101 bp reads on average.
Taxonomic and functional profiling for all cohorts
For metagenomic sequencing datasets (CA and SG cohorts) raw reads were quality filtered and trimmed using default options in famas (https://github.com/andreaswilm/famas). Reads that are potentially from human DNA were removed by mapping to the hg19 reference using BWA-MEM 46 (default parameters; coverage >80% of read).
The remaining reads were used for taxonomic profiling using MetaPhlAn with default For the 16S rRNA sequencing datasets (EN and SW cohorts) taxonomic classification was done by mapping reads to the SILVA database 48 (v123), using
BLASTn [7] . For each read, the species corresponding to the best hit (with identity > 97% and query coverage > 95%) was obtained and was taken as the source species of the read. In the case of multiple hits, the source taxon was computed as the Lowest Common Ancestor of the hit species. Reads assigned to each taxon were aggregated to Functional profiles computed with HUMAnN2 were compared between recoverers and non-recoverers in the SG and CA cohorts using the linear discriminant analysis approach in LEfSe 50 (version 1.1.0) to identify differentially abundant pathways.
Microbial community growth rate analysis
An in silico approach, originally proposed by Korem et al 31 , was used to compute the skew of DNA copy number starting from around the origin of replication to the termination region (peak-to-trough ration or PTR), as an estimate of growth rates for individual species in the microbiome from shotgun metagenomic data (PTRC1.1:
https://genie.weizmann.ac.il/software/bac_growth.html, default parameters). The median PTR value for species in a community was then used to represent community growth rate (CGR) for each sample (Suppl. Data File 5).
Profiling of carbohydrate active enzymes (CAZymes)
An in-house nucleotide gene database for CAZymes was created by downloading sequences from NCBI corresponding to Accession IDs for different CAZyme families 
Analysis of antibiotic resistance genes within gut microbiomes
Resistome profiling within a microbiome was performed similarly by mapping metagenomic reads using BWA-MEM (default parameters) to the ARG-ANNOT database 52 , and calculating the fraction of reads mapping to a resistance gene per kbp per million reads of the metagenome (RPKM). Kraken 53 was used with default parameters to obtain the taxonomic classification of reads and thus obtain the relative representation of different taxonomic groups within the resistome.
Clustering of species based on their carbohydrate degradation profiles
The substrate-specificities of different Glycoside hydrolase (GH) and Polysaccharide lyase (PL) families was obtained from previous studies 27, 28 . These included substrates such as plant cell wall carbohydrates, animal carbohydrates, peptidoglycans, fungal carbohydrates, sucrose/fructose, dextran, starch/glycogen and mucins. Copy number annotations for each GH and PL family in 125 bacterial species were obtained from a previous genome scale analysis of CAZymes in species belonging to the human gut microbiome 30 . Copy numbers of GH/PL genes within each of the 8 substrate specificities were aggregated and normalized to obtain an overall carbohydrate degradation profile for each bacterial species. Degradation profiles were then clustered using hierarchical clustering ('hclust' function in R with Euclidean distance and complete linkage clustering) to group species based on their enzyme repertoire for different categories of carbohydrates. Association of the identified recovery associated bacteria to one or more of these clusters was then evaluated using Fisher's exact test.
Construction of microbial 'food web' using association rule mining
To identify directed associations between bacterial species where the presence of one Library preparation and deep sequencing: Community DNA extraction was carried out using PowerSoil DNA Isolation Kit (MoBio Laboratories, California, USA) according to the manufacturer's protocol, without modifications. Library preparation and deep sequencing was performed as described for the human fecal samples obtained from the SG cohort (described earlier under the section 'DNA extraction and sequencing for SG cohort') with the following modification: 50 ng of DNA was used as input for preparation of libraries.
Taxonomic profiling: For obtaining the taxonomic profiles of the mouse gut metagenomes, reads were mapped to the NR database using DIAMOND 55 . The taxonomic classification of each sequence was then obtained by using the LCA-based approach in MEGAN 56 (default parameters, minimum score of 50).
Calculation of microbial biomass:
Bacterial biomass (up to a constant factor) was estimated by taking all reads classified to bacterial taxa and normalizing by nonmicrobial reads. Specifically, plant or host-derived reads were used, respectively, based on the assumption that the absolute amounts of their DNA would remain roughly constant in the analyzed mouse fecal samples. Similar trends were observed for both forms of normalization (default=plant normalized), normalization based abundances were found to correlate with qPCR estimates (plant normalized, r=0.73, p-value=10
host normalized, r=0.82, p-value=3.5×10 -6 ), and the observed differences between Bt and Bt+Ba groups versus other groups were also validated using qPCR (day 10, foldchange=94-170×). Note that sequencing based biomass estimates have the advantage that they allow us to subtract reads belonging to the gavaged species and are also not affected due to variations in 16S rRNA copy number across taxa.
qPCR Analysis: Absolute quantification of the 16S rRNA gene was done by quantitative PCR (qPCR). A pair of universal 16S bacterial primers 57 were used to amplify DNA extracted from the six different treatment groups on days 0, 3, 10 and 13 (Suppl. Table   1 ). Reactions were prepared on a 384-well plate, in triplicates, using 5 µL of PowerUp SYBR Green Master Mix (Thermo Fisher Scientific, Massachusetts, USA), 0.5 µL of 5µM primers and 1 µL of 10× diluted DNA, in a total volume of 10 µL for each reaction.
The ViiA 7 Real-Time PCR System (Thermo Fisher Scientific, Massachusetts, USA)
was used for qPCR with the following amplification parameters: 
Data Access
Illumina sequencing data for this study (mouse models) has been deposited to the Sequence Read Archive under project ID SRP142225 (reviewer metadata link: ftp://ftptrace.ncbi.nlm.nih.gov/sra/review/SRP142225_20180423_152835_2726e05d1c01c63b 0742fdbb3d89c0bc). abundance boxplots across cohorts for the six main species that were identified as being associated with microbiome recovery, in at least three out of four cohorts (see Table 2 for full list). Note that '*', '**' and ''***' denote cohort-specific FDR adjusted pvalues less than 0.1, 0.05 and 0.01 respectively. for microbiome recovery based on these observations. RABs from cluster 1 (Suppl. Fig.   S5 ) colonize the epithelial mucosa better because of their mucin degrading capabilities (step 1), and since they can also break down dietary plant and animal derived carbohydrates (step 2), they act as primary colonizers that facilitate the growth of nonprimary colonizers (step 3). Some of these secondary and tertiary colonizers may be better adapted to degrading plant and animal carbohydrates. The overall activity of primary and non-primary colonizers results in producing simpler sugars (promoting the growth of more bacteria (step 4) and short chain fatty acids (SCFAs), which are then utilized by colonocytes for their growth leading to increased mucin production (step 5).
This positive feedback loop promotes faster recovery of microbial biomass and community diversity to re-establish homeostasis in the gut. 
TABLES
